482Wire StoriesKyocera Plans New Manufacturing Plant in Japan’s Nagasaki Prefecture by 2026
Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity KYOTO, JAPAN–(BUSINESS WIRE)–Kyocera Corporation (President: Hideo Tanimoto;...
- 619Wire Stories
Dr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis who have...
- 615Wire Stories
Introducing THE BRIJ – A World of Arts and Culture
Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple creative projects...
- 471Wire Stories
Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney
MELBOURNE, Australia–(BUSINESS WIRE)–As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When asked about...
- 489Wire Stories
Dongying seeks trade opportunities in overseas markets
DONGYING, China–(BUSINESS WIRE)–Dongying, a city in East China’s Shandong province, has been helping local enterprises expand in international markets as part of...
- 477Wire Stories
A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia
SAN FRANCISCO–(BUSINESS WIRE)–A third of global businesses predict the current inflationary environment to continue for more than two years, according to new...
- 453News
Luxury beauty advisory SWISS REJU wins COSMOPOLITAN Best of the Best Panel’s Choice Award, celebrating exceptional body contouring results
HONG KONG SAR – Media Outreach – 19 December 2022 – Luxury beauty advisory SWISS REJU has been honored with “Best of...
- 491News
Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies
HONG KONG SAR – Media OutReach – 19 December 2022 – A research team led by Hong Kong Baptist University (HKBU) has...
- 460News
LOFTER Group assisted with “Gingko House”, the social enterprise, to hold a series of activities to bring warmth to the community this winter
HONG KONG SAR – Media OutReach – 19 December 2022 – LOFTER GROUP (“LOFTER” or “the Group”), a Hong Kong-based property developer...
- 690Wire Stories
ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer
Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in this patient...
